The present invention relates to the field of cancer. More specifically, the present invention provides compositions and methods useful for treating cancer characterized by the expression of mutant FAM190A proteins. In a specific embodiment, a method for treating a patient having a cancer characterized by a FAM190A intragenic rearrangement comprises the step of administering to the patient an agent that inhibits a biological function or reduces the level or expression of the FAM190A protein.
Post-doctoral researcher at Case Western Reserve University
Location:
Cleveland/Akron, Ohio Area
Industry:
Research
Work:
Case Western Reserve University - Cleveland/Akron, Ohio Area since Sep 2011
Post-doctoral researcher
Department of Oncology, Johns Hopkins University Dec 2008 - Apr 2011
Post-doc
Genetics Branch, NCI, NIH Sep 2003 - Sep 2008
Visiting Fellow